Skip to main content
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc. — Investor Relations & Filings

Ticker · TPST ISIN · US69014Q1013 US Professional, scientific and technical activities
Open in API
Filings indexed 986 across all filing types
Latest filing 2013-04-26 Proxy Solicitation & In…
Country US United States of America
Listing US TPST

About Tempest Therapeutics, Inc.

https://www.tempesttx.com/

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates and cell therapies. The company develops first-in-class therapeutics that combine tumor-targeted and immune-mediated mechanisms to treat cancer. Its lead product candidate is amezalpat (TPST-1120), an oral, selective PPARα antagonist being evaluated in a global, randomized combination study for hepatocellular carcinoma. In addition to its small molecule platform, the company is also developing dual-chimeric antigen receptor (CAR) T-cell programs.

Recent filings

Filing Released Lang Actions
DEF 14A
Proxy Solicitation & Information Statement
2013-04-26 English
424B3
Capital/Financing Update Classification · 95% confidence The document contains a prospectus supplement related to a resale of common stock shares, a Form 8-A registration statement for listing securities on NASDAQ, and a Form 8-K current report announcing the approval of the company's common stock for listing on NASDAQ. The key event is the announcement of the stock listing approval and the expected trading commencement date on NASDAQ. The document includes a press release attached as an exhibit announcing this listing. There are no financial statements or detailed financial data presented, nor is this a full annual or quarterly report. The document primarily serves as an official announcement of a capital market event (listing approval and trading commencement). This fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including stock listing announcements.
2013-04-26 English
8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It includes details about the registrant, the securities to be registered, and signatures but does not contain financial statements, earnings data, or management discussion. It is a regulatory filing related to securities registration rather than a financial report or announcement of voting results, management changes, or capital updates. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length is short (3054 characters) and it is not an announcement of a report but the actual filing form itself.
2013-04-25 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 25, 2013. It announces the approval of the company's common stock for listing on the NASDAQ Global Market and the expected trading start date. The document includes a press release as an exhibit and does not contain financial statements or detailed financial data. The length is 4140 characters, which is relatively short and the content is primarily an announcement of an event rather than a financial report or detailed filing. Therefore, this is a regulatory announcement type filing, specifically a Current Report on Form 8-K, which fits best under the Regulatory Filings (RNS) category as it does not fit other more specific categories like earnings release or capital update.
2013-04-25 English
S-8
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock incentive plans. It includes details about the stock incentive plan, the number of shares to be registered, and signatures of company officers and directors. It is not a financial report, earnings release, or management discussion, but rather a capital market filing related to securities registration. This type of filing corresponds to announcements or updates on capital structure or financing activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual registration statement, not just an announcement of a report.
2013-04-12 English
S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes detailed information about the company, the offering, risk factors, executive compensation, and other disclosures typical of a registration prospectus. This is not an annual report, earnings release, or any other financial report but a capital markets filing related to fundraising and securities registration. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and content confirm it is a full registration statement, not a brief announcement or certification.
2013-04-12 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.